IE 11 is not supported. For an optimal experience visit our site on another browser.

CDC advisory committee greenlights booster for certain groups


After FDA authorization last night, the CDC advisory committee approved a third dose of Pfizer’s Covid vaccine for those 65 and older, long-term care facility residents, and people ages 50 to 64 with underlying medical conditions.